Subsequent analyses indicated that the total protein levels of MEK1/2 and ERK1/2 remained constant following MCL treatment, whereas their phosphorylation levels significantly increased (Figure 5A,B). This evidence concerns the gene MAP2K1 and mantle cell lymphoma.